What can go wrong with the gate gland — and which failure is the emergency?
Prostate disease is three conversations and one emergency: BPH (the nearly universal enlargement — the stream, the nights, the most treatable chronic condition in men's health), prostatitis (the pain family — acute bacterial prostatitis, a genuine emergency with fever, versus chronic pelvic pain syndrome, the most common and most misunderstood urologic diagnosis in younger men), cancer (one in eight men lifetime; the PSA-era transformation from 'every cancer gets treated' to active surveillance as the majority choice for low-risk disease), and retention (the emergency outcome of untreated obstruction — a full bladder that cannot empty). The field's rules: retention is same-day care; fever with pelvic pain is urgent; blood in urine or semen is always evaluated; and men wait too long — the endurance culture this page exists to retire.
The universal story: the transition zone's DHT-driven growth compressing the urethra — the weakening stream, the double-void, the nocturia that counts. Highly treatable at every stage: behavioral timing, alpha-blockers (days), 5-ARIs (months), the minimally invasive era (UroLift, Rezūm), and surgery for the refractory end (TURP and the laser generation). The condition this page's whole shelf serves as adjunct. Not cancer, not caused by cancer, and never 'just aging.'
The emergency: bacterial infection of the gland — fever, chills, deep pelvic pain, burning urination, sometimes retention. Treated with prolonged antibiotics (the gland's barriers make courses long); can seed sepsis or abscess if delayed. The 'physician, same day, not the shelf' tier in its purest form.
The puzzle: chronic pelvic or perineal pain, often with urinary symptoms, in younger men — ~90% of 'prostatitis' cases, frequently without culturable bacteria, frequently lasting years before diagnosis. The UPOINT multimodal approach (symptom-pattern-targeted: pelvic floor PT, alpha-blockers, anti-inflammatories, stress work) is the modern frame. The condition that punishes single-bullet thinking — including the shelf's.
The one-in-eight: the most common male cancer after skin — often slow-growing, frequently screen-detectable, and transformed by the active-surveillance era (low-risk disease now most often monitored, not treated). The PSA decision is genuinely two-sided (Chapter 5); the diagnosis tier (MRI, fusion biopsy, grading) is precise; and the treatment menu (surgery, radiation, surveillance) is a real choice with real trade-offs. The conversation this page teaches honestly and hands to the urologist.
The emergency outcome: the obstruction finally winning — a bladder that fills and cannot empty, painful and complete. The catheter is the immediate answer; the cause (usually BPH, sometimes medication-triggered — Chapter 3's decongestant trap) is the workup. The event that ends the endurance era for most men who have one.
The structural flag: urinary infections in men are uncommon enough that each one earns evaluation — the prostate (prostatitis, enlargement), the anatomy (stones, strictures), and the bladder's emptying (our bladder page's residual check). 'Just another UTI' is a phrase that belongs to the other sex's epidemiology; in men, the infection is a clue until proven incidental.
Prostate prevention is honest about what exists — pattern associations, symptom literacy, and decisions made deliberately: